Results

Total Results: 515 records

Showing results for "renal".

441. Transparency of Reporting Requirements: Omega-3 Fatty Acids and Cardiovascular Disease (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/transparency-omega-3_research-protocol.pdf
     September 02, 2016 - for having non-CVD, non-DM related disease (eg, cancer, gastrointestinal disease, dialysis, chronic renal

442. Disposition of Comments for Technical Brief 29 Women Living With HIV-AIDS (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/women-hiv_disposition-comments.pdf
     November 21, 2016 - However the first vignette was so sui generis (transgender, silicone breast injections in a hotel room, renal

443. Systematic Review Search Strategy Development Tools: A Practical Guide for Expert Searchers (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/search-strategy-white-paper.pdf
     February 01, 2025 - End Stage Renal Disease and Depression: A Systematic Review.

444. Assessing Harms when Comparing Medical Interventions | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/methods-guidance-harms/methods
     May 01, 2020 - Adverse Effects of Cyclooxygenase 2 Inhibitors on Renal and Arrhythmia Events: Meta-analysis of Randomized

445. CER 220: Disposition of Comments Report for Comparative Effectiveness of Analgesics To Reduce Acute Pain in the Prehospital Setting (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-220-disposition-comments-analgesics-prehospital-setting.pdf
     September 03, 2019 - the APAP vs opioid studies conducted were in post traumatic headache, fractures, acute limb trauma, renal

446. FRN 29: Future Research Needs on Procalcitonin-Guided Antibiotic Therapy (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/procalcitonin-future_research.pdf
     August 01, 2014 - For patients with underlying stable chronic disease (e.g. diabetes, renal disease, but excluding immunocompromised … diabetes, renal disease, but excluding immunocompromised patients) and a high uncertainty of infection

447. Type-2-Diabetes-Medications-Update Surveillance (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
     December 31, 2013 - No clinically significant changes in renal function. … Glimepiride(sulfo nylureas) with metformin RCT 68 normoalbuminuric type 2 diabetes patients 1 year Renal

448. 8 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-harms_methods.pdf
     November 01, 2008 - Adverse Effects of Cyclooxygenase 2 Inhibitors on Renal and Arrhythmia Events: Meta-analysis of

449. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/health-careassociated-infections_research-protocol.pdf
     August 26, 2011 - avoid subclavian vein stenosis (CDC/HICPAC IA) • Use a fistula or graft in patients with chronic renal

450. 8 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/methodsguide_chou_assessing_harms_when_comparing.pdf
     November 01, 2008 - Adverse Effects of Cyclooxygenase 2 Inhibitors on Renal and Arrhythmia Events: Meta-analysis of

451. S131 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/s131.pdf
     October 01, 2007 - Palpitations 785.1 Parkinson disease 332.0, 332.1, 333.0 Peripheral vascular disease 440.xx, 443.9 Renal

452. S66 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/s66.pdf
     October 01, 2007 - conditions were solid organ transplantation, HIV/AIDS, cancer (except nonmelanoma skin cancers), and serious renal

453. Cell-Free-Dna-Appendix-C (xls file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cell-free-dna-appendix-c.xlsx
     September 01, 2024 - one of two locations: respiratory tract (lung and head/neck) and genitourinary (bladder, prostate, renal … (NR) 0.927 (0.907 to 0.946) NA NA NA NA NA NA NA NA NA NA NA NA NA NA None Ren 2016 Diagnostic CC Renal

454. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/01_arthritis_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - Barr virus-associated posttransplant lymphoproliferative disorder was observed in patients who had renal

455. Obesity (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity_hi_impact.pdf
     April 17, 2012 - also increases the risk of several types of cancers including colorectal, endometrial, esophageal, renal

456. Chicago-Area DEcIDE Center (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/off-label-use-research-priorities_research.pdf
     May 01, 2009 - Anxiety Bipolar b 13 olanzapine Schizophrenia Depression Dementia Anxiety 14 epoetin alfa Chron renal

457. Research White Paper Registries in Accountable Care Addendum Registries for Evaluating Patient Outcomes Third Edition (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/wysiwyg/accountable-care-registries-guide-3rd-ed-addendum-white-paper-2018-5.pdf
     January 01, 2018 - comparison tables showing predictive ratios for body system or disease group categories, such as end stage renal

458. Abnormal-Uterine-Bleeding Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_executive.pdf
     March 01, 2013 - • Who are healthy, and without renal impairment, hepatic impairment, intestinal disease, thyroid

459. Data-Points-7-Tables (xls file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/data-points-7-tables.xls
     August 25, 2011 - Age, Gender, and Race Note: A dash signifies a small cell count (less than 11); ESRD = end stage renal

460. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_executive.pdf
     October 01, 2010 - growth hormone deficiency, idiopathic short stature, Turner syndrome, Prader-Willi syndrome, and chronic renal